Date: 2011-08-26
Type of information: Company acquisition
Acquired company: Bluefish Pharmaceuticals (Sweden)
Acquiring company: BMM Pharma (Sweden)
Amount: € 4.16 million
Terms: Medivir subsidiary BioPhausia AB has reached an agreement to sell its generics business in the form of subsidiary BMM Pharma AB to Bluefish Pharmaceuticals AB for SEK 26 m plus the value of inventories, some SEK 12 m. The staff of BMM Pharma will not transfer in the acquisition.
Details:
Related: Generic
